Leith Wheeler Investment Counsel Ltd. Has $40.07 Million Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Leith Wheeler Investment Counsel Ltd. lowered its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 7.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 578,968 shares of the company's stock after selling 48,791 shares during the quarter. Henry Schein comprises approximately 2.9% of Leith Wheeler Investment Counsel Ltd.'s investment portfolio, making the stock its 5th largest holding. Leith Wheeler Investment Counsel Ltd. owned about 0.46% of Henry Schein worth $40,065,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in HSIC. Versant Capital Management Inc increased its position in shares of Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after acquiring an additional 335 shares during the last quarter. Venturi Wealth Management LLC raised its position in Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC boosted its stake in Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after acquiring an additional 323 shares during the last quarter. Smartleaf Asset Management LLC grew its position in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after acquiring an additional 143 shares during the period. Finally, City State Bank bought a new position in shares of Henry Schein during the 4th quarter valued at approximately $55,000. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Price Performance

Shares of HSIC stock traded down $0.51 on Thursday, reaching $64.46. The company's stock had a trading volume of 1,337,518 shares, compared to its average volume of 1,620,701. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The stock's 50 day simple moving average is $68.22 and its 200-day simple moving average is $71.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $7.90 billion, a P/E ratio of 26.53, a PEG ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business's revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.66 EPS. As a group, equities analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company's stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company's stock.

Analysts Set New Price Targets

A number of research firms have issued reports on HSIC. StockNews.com downgraded Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Jefferies Financial Group boosted their price objective on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price for the company. Piper Sandler dropped their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday. Finally, Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and lifted their price objective for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $80.20.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.